Regional inequalities threatening Europe’s biosimilars market
European Pharmaceutical Review
NOVEMBER 16, 2023
The report noted that biosimilar adoption levels vary significantly across Europe because of differences in baseline use of biologics, biosimilar reimbursement, procurement, policies, and education, based on research published in a paper in the Journal of Market Access & Health Policy in 2017.
Let's personalize your content